BioPharma Drive: Drug Pricing
AUGUST 23, 2023
The company doesn’t know if the needles have caused retinal vasculitis in some people receiving its geographic atrophy drug Syfovre, but is no longer recommending their use.
FDA Law Blog: Biosimilars
AUGUST 24, 2023
Hyman, Phelps & McNamara, P.C. (“HP&M”) is is proud to announce that 14 of the Firm’s attorneys have been selected to the 2024 edition of The Best Lawyers in America®. Newly recognized this year are attorneys Josephine M. Torrente (FDA Law), Michelle L. Butler (FDA Law), Sara W. Koblitz (FDA Law), Allyson B. Mullen (FDA Law), and Anne K. Walsh (FDA Law), as well as McKenzie E.
Drugs.com
AUGUST 25, 2023
FRIDAY, Aug. 25, 2023 -- Paper straws, meant to be an eco-friendly alternative to plastic, may not be better for the environment, a new study concludes, warning that they also contain “forever chemicals” that can harm human.
Drug Target Review
AUGUST 25, 2023
What makes RRx-001 a first-in-class hypoxia-activated therapeutic, and how does its dual mechanism of action differ from traditional cancer treatments? Most, if not all, traditional cancer treatments are single minded. Their mechanisms of action are completely consistent no matter the tissue or environment in which they find themselves. RRx-001 (nibrozetone) is different because in tissues where 3 “Hs” are present, namely hypoxia (low oxygen), hyperaemia (over-vascularisation), and high hydrogen
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
AUGUST 22, 2023
Billing itself as both a scientific and investment partner, Foundery aims to provide research grants and drug development support to researchers developing new immunotherapies.
Perficient: Drug Development
AUGUST 24, 2023
The transition from a wholesale-centric business model to include a new direct-to-consumer (D2C) approach presents lucrative opportunities alongside a suite of technical and operational intricacies to consider. While the move brings manufacturing companies closer to end consumers, it also requires several considerations spanning content creation, post-purchase support, and overall brand experience.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
PLOS: DNA Science
AUGUST 24, 2023
As autumn looms, we’re enjoying the last bites of sweet, juicy watermelon. Conventional agriculture has molded our fruits and veggies to suit our palates, gradually crafting domesticated Citrullus lanatus from three ancestral melon species. But the process may have also removed valuable traits. Researchers at the Boyce Thompson Institute in Ithaca, New York, have analyzed genomes of watermelon and its ancestors, revealing traits that early breeders may have inadvertently removed in their q
BioPharma Drive: Drug Pricing
AUGUST 25, 2023
According to one analyst, the approval was the last hurdle keeping Sandoz’s Tyruko from directly competing in the U.S. market against Biogen’s inflammation-regulating medicine Tysabri.
Drug Target Review
AUGUST 24, 2023
The focus of this study is on Growth Differentiation Factor-15 (GDF-15), a cytokine known for its critical role in feto-maternal tolerance, which has now been found to be hijacked by tumours to evade immune attack. We will explore how GDF-15 impacts the tumour microenvironment and hinders the infiltration of T cells into the tumour, as well as the implications of neutralising GDF-15 to reverse its inhibitory effects and sensitise tumours to anti-PD-1 treatment.
Drugs.com
AUGUST 25, 2023
FRIDAY, Aug. 25, 2023 -- Alice Tapper felt deathly ill, suffering from severe abdominal pain, a 102-degree fever and vomiting. Emergency room doctors found that Alice -- the daughter of CNN anchor Jake Tapper -- had a rapid pulse of 135 beats per.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Perficient: Drug Development
AUGUST 24, 2023
In the dynamic world of web development, where user expectations are higher than ever and application complexity continues to grow. The need for efficient data retrieval and flexible APIs has become paramount. Enter GraphQL, a revolutionary query language for APIs that is reshaping how data is requested, fetched, and managed. In this comprehensive exploration, we’ll dive deep into the essence of GraphQL, its core principles, benefits, and real-world applications.
BioPharma Drive: Drug Pricing
AUGUST 23, 2023
Data inadvertently published from a closely watched lung cancer study suggest a drug blocking the protein TIGIT may help extend survival, a finding that boosted shares of other developers.
Antidote
AUGUST 21, 2023
Before any new treatment is able to be approved, it is required to go through the vigorous testing process known as clinical trials. These trials are aimed at determining whether or not a drug, medical device, therapy, or other type of intervention is safe and effective for the public.
Drugs.com
AUGUST 25, 2023
FRIDAY, Aug. 25, 2023 -- It might not seem like constipation or difficulty swallowing could signal a neurological problem, but new research suggests that these gut conditions could be an early indicator of Parkinson’s disease. Gastrointestinal.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Perficient: Drug Development
AUGUST 22, 2023
Aria labels provide alternate text to adaptive technology tools such as screen readers. This helps website visitors navigate the site more accurately. One use case for aria-labels is on html anchor tags. Sitecore does not a way to manage this text by default. Follow along and I’ll show you how to modify the various link dialogs and give content authors the ability to manage this text.
SCIENMAG: Medicine & Health
AUGUST 22, 2023
PROVIDENCE, R.I. [Brown University] — One of the most common and practically useful experiments in all of fluid dynamics involves holding an object in air or submerging it fully underwater, exposing it to a steady flow to measure its resistance in the form of drag.
Drug Target Review
AUGUST 22, 2023
This Q&A explores how pre-clinical research is being used to identify potential therapies for Huntington’s disease, a devastating condition that currently lacks disease- modifying treatments. By leveraging the power of naturally occurring antibodies , Alchemab’s research has significant potential to transform the landscape of neurodegenerative disease research and improve the lives of those affected by these challenging conditions.
Drugs.com
AUGUST 25, 2023
FRIDAY, Aug. 25, 2023 -- Coupons for tobacco products appear to have a big impact on relapse rates for smokers who have recently kicked the habit, researchers report. A study of more than 5,000 former smokers who participated in a national survey.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Perficient: Drug Development
AUGUST 21, 2023
If you’ve been following Sitecore’s architectural movement over the last few years, a lot has changed. Instead of the “all-in-one” approach of Sitecore XP, XM Cloud , and Headless encourage a composable architecture – one where Sitecore itself offers 11 SaaS products categorized into three clouds : Content Cloud, Engagement Cloud, and Commerce Cloud.
BioPharma Drive: Drug Pricing
AUGUST 22, 2023
The pharma’s suit, which claims Medicare’s new power to negotiate certain drug prices is unconstitutional, comes days before the agency will reveal the first 10 medicines to be included under the plan.
Drug Target Review
AUGUST 21, 2023
To unravel the mysteries behind the treatment response, researchers from the Department of Otolaryngology/Head and Neck Surgery at UNC School of Medicine collaborated with experts from Yale Cancer Center, the Yale Head and Neck Cancer Specialised Program of Research Excellence (SPORE), and the ECOG-ACRIN Cancer Research Group. Their study, published in Proceedings of the National Academy of Sciences , unveiled the existence of two distinct subtypes of HPV + head and neck cancers.
Drugs.com
AUGUST 24, 2023
THURSDAY, Aug. 24, 2023 -- Cancer patients with immune systems weakened by treatment are among the groups most concerned about the continued spread of COVID-19 and the chance of the infection becoming severe. New research suggests more guidance on.
Perficient: Drug Development
AUGUST 22, 2023
To meet clinical, business, and evolving consumer needs, healthcare and life sciences organizations are focused on care delivery that enables innovation in patient engagement, data and analytics, and virtual care. According to Gartner’s 2022 Industry Cloud Survey , about 40% of IT leaders say they have started to adopt industry cloud platforms, with another 15% in pilots; another 15% are considering deployment by 2026.
Fierce BioTech
AUGUST 24, 2023
In this podcast, Dan Fisher, managing director for IPM.ai, a division of Real Chemistry, explains how real world health data generated from more than 300 million de-identified patient records can h | Using artificial intelligence to predict and uncover de-identified rare disease patients shortens the time to diagnosis, benefiting both patients and life science companies.
BioPharma Drive: Drug Pricing
AUGUST 23, 2023
The funding for Rapport Therapeutics saw participation from a series of so-called crossover investors, many of which have pulled back from biotech startups in recent years.
Drugs.com
AUGUST 25, 2023
FRIDAY, Aug. 25, 2023 -- The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced.
SCIENMAG: Medicine & Health
AUGUST 22, 2023
Amsterdam, Netherlands – 23 Aug 2023: Hours of inactivity during childhood could be setting the stage for heart attacks and strokes later in life, according to research presented at ESC Congress 2023.
Perficient: Drug Development
AUGUST 23, 2023
Today’s environment is relentlessly volatile. It rewards speed over size, agility over efficiency, and cross-functional flow over rigid structure. You must be ready to shift and scale your teams as priorities change. The way forward requires a comprehensive digital strategy that defines the capabilities, agility, and alignment to put you on the right side of digital disruption.
BioPharma Drive: Drug Pricing
AUGUST 24, 2023
Bristol Myers Squibb is among those backing the startup, which claims the manufacturing capacity at its New Jersey plant can surpass that of conventional CDMO facilities.
Drugs.com
AUGUST 24, 2023
THURSDAY, Aug. 24, 2023 -- Stroll past the supplements in any drugstore and you’ll find broad claims about fish oil helping everything from heart and brain health, to joints, eyes and immune systems.
Conversations in Drug Development Trends
AUGUST 23, 2023
Patients are the backbone of clinical trials, playing an essential role in the drug development process. However, patients also play a vital role in engaging directly with the FDA. This engagement is often less understood and is underutilized by sponsors, meaning a significant element of the trial and drug experience is missed during sponsor engagement with the FDA.
SCIENMAG: Medicine & Health
AUGUST 22, 2023
ROCKVILLE, Md.—For the first time, researchers have discovered that the ventral tegmental area (VTA) of the brain—a key structure involved in motivation and reward appreciation has altered connectivity patterns with specific brain regions in patients with obesity.
BioPharma Drive: Drug Pricing
AUGUST 21, 2023
Analysts expect the approval of Ingrezza in Huntington’s patients with a movement disorder known as chorea to intensify a commercial battle between Neurocrine and Teva.
Expert insights. Personalized for you.
98 
Let's personalize your content